Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome) Latest Advances
Find the Latest Research About Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1439 publications
Dynamic Angiography Demonstrating Discogenic Bow Hunter Syndrome.
Journal: Stroke
Published: June 22, 2026
Hunter Syndrome: The Pediatric Surgeon's Point of View.
Journal: The Israel Medical Association journal : IMAJ
Published: May 18, 2026
Symptomatic Bilateral Vertebral Artery Aneurysms due to C1-2 Hypermobility (Bow Hunter's Syndrome).
Journal: Stroke
Published: April 27, 2026
First-in-class blood-brain barrier shuttle wins FDA nod for Hunter syndrome.
Journal: Nature reviews. Drug discovery
Published: March 28, 2026
Synthesis of a C-2 Functionalized l-Iduronic Acid Derivative as a Candidate Pharmacological Chaperone for MPS II (Hunter Syndrome).
Journal: Chemistry, an Asian journal
Published: March 06, 2026
Harmonizing Perspectives on MPS II Care in Türkiye: A Delphi Study Towards Treatment Management Consensus.
Journal: Healthcare (Basel, Switzerland)
Published: February 20, 2026
A novel IDS variant associated with an isolated ocular phenotype in Hunter syndrome.
Journal: Documenta ophthalmologica. Advances in ophthalmology
Published: February 18, 2026
Bow Hunter's syndrome on a persistent first intersegmental artery course in extreme old age: A case report.
Journal: Surgical neurology international
Published: February 03, 2026
Merging evans syndrome with mucopolysaccharidosis type II: a case report.
Journal: Frontiers in pediatrics
Published: January 09, 2026
An Intravenous Brain-Penetrant Enzyme Therapy for Mucopolysaccharidosis II.
Journal: The New England journal of medicine
Published: December 30, 2025
Last Updated: 06/30/2026